[1] | Suárez, M., Romero, M.P., Ramo, T., Macià, A., Motilva, M.J., “Methods for preparing phenolic extracts from olive cake for potential application as food antioxidants.” J Agric Food Chem, 57(4), 1463-1472, 2009. |
|
[2] | Tuck, K.L., Hayball, P.J., “Major phenolic compounds in olive oil: Metabolism and health effects.” J Nutr Biochem, 13, 636-644, 2002. |
|
[3] | Baldioli, M., Servili, M., Perretti, G., Montedoro, G., “Antioxidant activity of tocopherols and phenolic compounds of virgin olive oil.” J Am Oil Chem Soc, 73, 1589-1593, 1996. |
|
[4] | Ellis, L.Z., Liu, W., Luo, Y., Okamoto, M., Qu, D., Dunn, J.H., Fujita, M., “Green tea polyphenol epigallocatechin-3-gallate suppresses melanoma growth by inhibiting inflammasome and IL-1 secretion.” Biochem Biophys Res Commun, 414, 551-556, 2011. |
|
[5] | John, C.M., Sandrasaigaran, P., Tong, C.K., Adam, A., Ramasamy, R., “Immunomodulatory activity of polyphenols derived from Cassia auriculata flowers in aged rats.” Cell Immunol 271, 474-479, 2011. |
|
[6] | Soler-Rivas, C., Espín, J.C., Wichers, H.J., “Oleuropein and related compounds.” J Sci Food Agric, 80, 1013-1023, 2000. |
|
[7] | Benavente-Garcia, O., Castillo, J., Lorente, J., Ortuno, A., del Rio, J., “Antioxidant activity of phenolics extracted from Olea europaea L. leaves.” Food Chem, 68, 457-462, 2000. |
|
[8] | Hamdi, H.K., Tavis, J.H., Castellon, R., “Methods for Inhibiting Angiogenesis.”, Patent WO/2002/094193, 2002. |
|
[9] | Masella, R., Varì, R., D'Archivio, M., di Benedetto, R., Matarrese, P., Malorni, W., Scazzocchio, B., Giovannini, C., “Extra virgin olive oil biophenols inhibit cell-mediated oxidation of LDL by increasing the mRNA transcription of glutathione-related enzymes.” J Nutr, 134, 785-791, 2004. |
|
[10] | Cumaoglu, A., Ari, N., Kartal, M., Karasu, Ç., “Polyphenolic extracts from Olea europea L. protect against cytokine-induced-cell damage through maintenance of redox homeostasis.” Rejuv Res, 14, 325-334, 2011. |
|
[11] | Proposed International Guidelines for Biomedical Research Involving Human Subjects. The Council for International Organisation of Medical Sciences. Geneva, 1982. |
|
[12] | Summary of American Heart Association Diet and Lifestyle Recommendations Revision 2006. Arterioscler Thromb Vasc Biol, 26, 2186-2191, 2006. |
|
[13] | European Diabetes Policy Group 1999. A desktop guide to type 2 diabetes mellitus. Diabet Med, 16, 716-730, 1999. |
|
[14] | Heding, L.G., “Determination of total serum insulin (IRI) in insulin-treated diabetic patients.” Diabetologia, 8, 260-266, 1972. |
|
[15] | Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F., Turner, R.C., “Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.” Diabetologia, 28, 412-419, 1985. |
|
[16] | Wallace, T.M., Levy, J.C., Matthews, D.R., “Use and abuse of HOMA modeling.” Diabetes Care, 27, 1487-1495, 2004. |
|
[17] | Klose, S., Borner, K., “Enzymatische Bestimmung des Gesamtcholesterins mit dem [Enzymatic dosage of total cholesterolemia by Greiner Selective Analyzer (GSA II)].” J Clin Chem Clin Biochem 15, 121-130, 1978. |
|
[18] | Wahlefeld, A.W., “Triglycerides determination after enzymatic hydrolysis.” In: Methods of Enzymatic Analysis. Ed. H. U. Bergmeyer, 2nd English ed. Academic Press, New York (USA) 1974; pp. 18-31. |
|
[19] | Havel, R.J., Eder, H.A., Bragdon, J.H., “The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.” J Clin Invest, 34, 1345-1353, 1955. |
|
[20] | Friedewald, W.T., Levy, R.I., Fredrickson, D.S., “Estimation of the concentration of low density lipoprotein in plasma, without use of the preparative ultracentrifuge.” Clin Chem, 18: 499-502, 1972. |
|
[21] | Holvoet, P., Vanhaecke, J., Janssens, S., Van de Werf, F., Collen, D., “Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease.” Circulation, 98, 1487-1494, 1998. |
|
[22] | Rifai, N., Tracy, R.P., Ridker, P.M., “Clinical Efficacy of an Automated High-Sensitivity C-Reactive Protein Assay.” Clin Chem, 45(12), 2136-2141, 1999. |
|
[23] | American Diabetes Association 2022., “Standards of Medical Care in Diabetes.” Diabetes Care, 45(Suppl 1), S1-S259, 2022. |
|
[24] | Winer, B.J., “Statistical Principles in Experimental Design.” 2nd ed., McGraw-Hill, New York (USA) 1971. |
|
[25] | Zheng, S., Huang, K., Tong, T., “Efficacy and Mechanisms of Oleuropein in Mitigating Diabetes and Diabetes Complications.” J Agric Food Chem, 69(22), 6145-6155, 2021. |
|
[26] | Vazquez-Roncero, A., Maestro-Duran, R., Graciani-Constante, E., “Phenolic compounds in olive fruits. II: Polyphenols in vegetation water.” Grasas Aceites, 25, 341-345, 1974. |
|
[27] | Servili, M., Baldioli, M., Selvaggini, R., Miniati, E., Macchioni, A., Montedoro, G., “High-performance liquid chromatography evaluation of phenols in olive fruit, virgin olive oil, vegetation waters, and pomace and 1D- and 2D-nuclear magnetic resonance characterization.” J Am Oil Chem Soc, 76, 873-882, 1999. |
|
[28] | Mulinacci, N., Romani, A., Galardi, C., Pinelli, P., Giaccherini, C., Vincieri, F.F., “Polyphenolic content in olive oil waste waters and related olive samples.” J Agric Food Chem, 49, 3509-3514, 2001. |
|
[29] | Arts, I.C., Sesink A.L., Hollman P.C., “Quercetin-3-glucoside is transported by the glucose carrier SGLT1 across the brush border membrane of rat small intestine.” J Nutr, 132(9), 2823, 2002. |
|
[30] | Carnevale, R., Silvestri, R., Loffredo, L., Novo, M., Cammisotto, V., Castellani, V., Bartimoccia, S., Nocella, C., Violi, F., “Oleuropein, a component of extra virgin olive oil, lowers postprandial glycaemia in healthy subjects.” Br J Clin Pharmacol 84(7), 1566-1574, 2018. |
|
[31] | Qabaha, K., Al-Rimawi, F., Qasem, A., Naser, S.A., “Oleuropein is responsible for the major anti-inflammatory effects of olive leaf extract.” J Med Food, 21(3), 302-305, 2018. |
|